Inactive Instrument

Analyst Reco. Healthcare Trust America Nyse

Equities

HTA

US42225P5017

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Citigroup Cuts Healthcare Realty Trust Price Target to $13 From $17.50, Maintains Neutral Rating	19/03	MT
JPMorgan Cuts Price Target on Healthcare Realty Trust to $17 From $19, Maintains Overweight Rating	06/03	MT
Stifel Downgrades Healthcare Realty Trust to Hold Form Buy, Price Target is $15	20/02	MT
Wedbush Downgrades Healthcare Realty Trust to Neutral From Outperform, Says Up Against Elevated Investor Scrutiny With Slim Margin for Error in Near-Term; Adjusts PT to $15 From $19	20/02	MT
Deutsche Bank Initiates Coverage on Healthcare Realty Trust With Hold Rating, $18 Price Target	30/01	MT
Wells Fargo Trims Price Target on Healthcare Realty Trust to $16 From $17, Maintains Equalweight Rating	13/11	MT
BTIG Upgrades Healthcare Realty Trust to Buy From Neutral, Price Target is $17	24/23/24	MT
JPMorgan Upgrades Healthcare Realty Trust to Overweight From Neutral, Price Target is $19	12/23/12	MT
Scotiabank Cuts Healthcare Realty Trust's Price Target to $17 From $19, Maintains Sector Perform Rating	10/23/10	MT
Wells Fargo Adjusts Healthcare Realty Trust's Price Target to $17 From $19, Equalweight Rating Kept	10/23/10	MT
BMO Capital Cuts Price Target on Healthcare Realty Trust to $17 From $20, Keeps Market Perform Rating	06/23/06	MT
Wedbush Starts Healthcare Realty Trust at Outperform With $17 Price Target	03/23/03	MT
Citigroup Adjusts Price Target on Healthcare Realty Trust to $17 From $19, Maintains Neutral Rating	22/23/22	MT
Barclays Adjusts Price Target on Healthcare Realty Trust to $24 From $25, Maintains Overweight Rating	11/23/11	MT
Barclays Adjusts Price Target on Healthcare Realty Trust to $25 From $24, Keeps Overweight Rating	11/23/11	MT
Healthcare Realty Trust's First Q1 Normalized FFO Since Merger With Healthcare Trust of America Beats Analysts' Expectations	09/23/09	MT
Barclays Adjusts Price Target on Healthcare Realty Trust to $24 From $28, Maintains Overweight Rating	29/23/29	MT
Credit Suisse Downgrades Healthcare Realty Trust to Neutral From Outperform, Lowers Price Target to $20 From $23	06/23/06	MT
Fitch Affirms Healthcare Realty Trust at 'BBB'; Outlook Stable	22/23/22	AQ
Citigroup Downgrades Healthcare Realty Trust to Neutral From Buy, Adjusts Price Target to $20 From $22.50	14/22/14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Healthcare Trust America Nyse

Equities

HTA

US42225P5017

Analyst Reco.

Filters